Reno, Nevada (March 10, 2022) – This February, Saint Mary’s Regional Medical Center was the site of the state’s first Aquablation case, a therapy intended for patients experiencing symptoms of benign prostatic hyperplasia (BPH), also known as an enlarged prostate. As the first program in Nevada to offer the advanced, minimally invasive treatment, Saint Mary’s sought to improve access for Northern Nevadans to industry-leading, advanced medical technology.
“We are so excited to offer Aquablation Therapy to our patients,” said Tiffany Coury, CEO of Saint Mary’s Health Network. “This is an innovative technique that provides our patients with the highest standard of care, offering improved outcomes and shorter recovery times .”
As the name indicates, Aquablation Therapy includes a high-pressure water jet used to carefully remove targeted tissue. It is precise, consistent, and offers long-term relief no matter how advanced symptoms have become. As a resective procedure, Aquablation Therapy is performed under anesthesia, and typically takes less than an hour. There are significantly less side effects associated with Aquablation as compared to other surgical alternatives, and it has quickly become the method of choice for area specialists.
“Aquablation leverages state-of-the-art technology to deliver a safe, efficient, and extremely effective treatment for men suffering from symptoms of enlarged prostate,” added Dr. Matthew McCormack, a urologist with Urology Nevada. “My colleagues and are thrilled to welcome this technology to Northern Nevada.”
To learn more about Aquablation Therapy, visit this link and talk to your provider to see if the procedure might be right for you.